Deprecated: Creation of dynamic property Penci_AMP_Post_Template::$ID is deprecated in /home/u444474283/domains/gwcmag.com/public_html/wp-content/plugins/penci-soledad-amp/includes/class-amp-post-template.php on line 46

Deprecated: Creation of dynamic property Penci_AMP_Post_Template::$post is deprecated in /home/u444474283/domains/gwcmag.com/public_html/wp-content/plugins/penci-soledad-amp/includes/class-amp-post-template.php on line 47
GLP-1 Receptor Agonists: European Drug Regulator Asks Makers For Evidence Of Self-harm - GWC Mag - Your Trusted Source For Green Technology, Sustainability, And Environmental Innovation GLP-1 Receptor Agonists: European Drug Regulator Asks Makers For Evidence Of Self-harm - GWC Mag - Your Trusted Source For Green Technology, Sustainability, And Environmental Innovation
Green Health & Wellness

GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm – GWC Mag

gwcmag032 views

The European Medicines Agency (EMA) has asked some licence holders of GLP-1 receptor agonists for evidence into associations with suicidal ideation and self-harm as part of a review. These drugs include Ozempic (semaglutide), Saxenda (liraglutide), and Wegovy (semaglutide) and are used to treat type 2 diabetes and in weight management.

The review was triggered by the Icelandic Medicines Agency in July after reports of suicidal thoughts and self-injury in people using liraglutide and semaglutide. The authorities have so far retrieved and analysed about 150 reports of possible cases of self-injury and suicidal thoughts.

The EMA’s …

Related posts

Gossiping can benefit mental health, but also presents risks, experts say – GWC Mag

Johnson & Johnson (JNJ) earnings Q1 2024 – GWC Mag

UnitedHealth says Change Healthcare cyberattack cost it $872 million – GWC Mag

Add Comment